Skip to main content
PRME logo

PRME · Prime Medicine, Inc. · Holdings

Track PRME — free
$3.55 -0.29 (-7.55%) At close · Nov 20
Market Cap
$645.82M
Shares
181.92M
Volume · Nov 20 6.13M Avg daily vol (3M) 4.63M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 188
Total Value: $377,179,993
Total Shares: 123,463,214
Showing 1–100 of 194 holdings by value · page 1 of 2

Institutional Ownership Trend

16 quarters

Holder Concentration

Share of 13F common-share value, across 188 filers with any position, options included · Δ vs Jun 30, 2026
Top Holder
15.0%
Dec 2023 → Sep 2026 · range 15.0% – 25.7%
−0.6 pts
Top 5
50.2%
Dec 2023 → Sep 2026 · range 43.8% – 56.9%
+5.8 pts
Top 10
65.5%
Dec 2023 → Sep 2026 · range 61.3% – 80.4%
+4.1 pts
HHI
657
Dec 2023 → Sep 2026 · range 565 – 1,002
Broadly held+92

Who Holds PRME

Last 8 quarters through Sep 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Sep 30, 2026: 187 filers, like-for-like change +15.8%; actively managed books +24.4%; index-like books -2.1%.

Holder type Share Filers Change
Registered adviser 36.7% 92 -1.4%
Exempt adviser 16.0% 5 +4226.9%
Adviser 3.9% 4 -11.8%
Bank 12.3% 13 -6.7%
Insurer 0.1% 3 +320.5%
Broker-dealer 0.3% 3 -30.0%
Benefit plan 0.1% 4 -1.0%
Non-US 0.3% 6 +10.9%
Holding company 12.8% 7 -0.4%
Unknown 17.6% 50 +0.6%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 2 holders with no observed 2026-06-30 13F and 4 holders with no observed 2026-09-30 13F.

Conviction and Crowding

187 13F filers, quarter ended Sep 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
0
0.000% of filers hold it in their top 10
Jun 30, 2026: 0
Holders above 5%
0
median weight 0.000%
Jun 30, 2026: 0
Crowding
28.4%
of shares outstanding, 76th percentile
Jun 30, 2026: 19.2%
Private-fund advisers
27.2%
of shares outstanding
Institutional ownership
68.1%
126.3% of the estimated free float above 100%: filers can report lent or client shares more than once
Top 10 holders
65.5%
of 13F shares, Herfindahl 0.066
Active holders
+24.4%
like-for-like share change of active filers
5% stakes on record
4
1 13D, 3 13G (1 institutional, 2 passive, 0 exempt)
How long holders have held it value-weighted 10.1 quarters
Under 1 year 27.4% 1 to 3 years 23.7% 3 years or more 48.9% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net sellers of $1,135,954 (3 buying, 5 selling).

Estimated Holder Cost Basis

Quarter ended Sep 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$6.50
estimated per share
Jun 30, 2026: $7.18
Quarter-end price
$3.05
implied by 13F values
Estimated gain or loss
-53.0%
price against the estimated cost
Estimated at a loss
99.7%
of costed 13F value

Estimated cost covers 94.4% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies PRME's active holders also own, quarter ended Sep 30, 2026
# Company Shared holders
1 BEAM Beam Therapeutics Inc. 9
2 ABSI Absci Corp 6
3 ARCT Arcturus Therapeutics Holdings Inc. 3
4 MAZE Maze Therapeutics, Inc. 5
5 FRNM Freenome, Inc. 4
6 RXRX Recursion Pharmaceuticals, Inc. 4
7 PBLS Parabilis Medicines, Inc. 4
8 ALMR Alamar Biosciences, Inc. 3
9 WRD WeRide Inc. 3
10 PLRX Pliant Therapeutics, Inc. 3

Shareholder Targets

13F filers that own its peers but not PRME, quarter ended Sep 30, 2026

Found through its holder-overlap peers: BEAM, ABSI, ARCT, MAZE, FRNM, RXRX, PBLS, ALMR, WRD, PLRX, TSHA, LUNR, AGIO, XNCR, PACB, PONY, NRIX, NTLA, SDGR, TEM. 1,014 filers in all.

# Filer In peers
1 RA CAPITAL MANAGEMENT, L.P. Registered adviser, Concentrated $1,464,003,470 4 held
2 BAILLIE GIFFORD & CO Adviser, Diversified active $743,112,161 4 held
3 SOFTBANK GROUP CORP. Unknown, Concentrated $547,491,777 3 held
4 PERCEPTIVE ADVISORS LLC Registered adviser, Diversified active $325,906,657 2 held
5 Deep Track Capital, LP Adviser, Diversified active $291,185,277 4 held
6 FRANKLIN RESOURCES INC Adviser, Diversified active $281,649,295 10 held
7 RTW INVESTMENTS, LP Registered adviser, Diversified active $262,024,115 4 held
8 Vestal Point Capital, LP Registered adviser, Concentrated $259,198,400 3 held
9 PRIMECAP MANAGEMENT CO/CA/ Registered adviser, Diversified active $246,502,382 1 held
10 BAKER BROS. ADVISORS LP Registered adviser, Concentrated $219,110,075 7 held

Fund Ownership of PRME by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 11.05% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.07% 3,773,008
Index ETFs 8.97% 16,324,124
Active ETFs 2.87% 5,212,804
Active funds 3.95% 7,178,051
Unclassified 0.02% 40,000
All registered funds 17.88% 32,527,987
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Jun 30, 2026
New
25
Increased
68
Decreased
58
Sold Out
23
Unchanged
35

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: 0
Institutional value: -4.2%
Shares held: +15.8%

Top Buyers

vs Jun 30, 2026
Institution Added Now Holds Open

Top Sellers

vs Jun 30, 2026
Institution Sold Now Holds Open

Top New Positions

vs Jun 30, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Jun 30, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 194
Export CSV
Holder Value (USD) % of 13F Shares Own % Change Type Filed Open

Showing the top 100 of 194 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1894562 CUSIP 74168J101 13F (30d) 192 filings 177 filers Visit website Investor relations